1. Comparatively analyze the known physical decay emissions of diagnostic or therapeutic radionuclides to predict their relative utility.
  2. Summarize the challenges and implications of accelerator target materials’ isotopic enrichment for the purity and safety of nuclear medicine drugs.
  3. Evaluate the potential efficacy of diagnostic and therapeutic targeted radionuclide “pairs” as drug combinations in nuclear medicine.

Zoom info: https://uwmadison.zoom.us/s/95210958346?pwd=bWVjZHVFWkpBUFBEMGplbmFQRmhzUT09

Session date: 
04/13/2022 - 8:00am to 9:00am CDT
Clinical Science Center, G5/119
600 Highland Ave
Madison, WI 53792
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
Dr. Jonathon Engle